U.S. flag

An official website of the United States government

NM_007194.4(CHEK2):c.170C>T (p.Ser57Phe) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Sep 1, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000160445.16

Allele description [Variation Report for NM_007194.4(CHEK2):c.170C>T (p.Ser57Phe)]

NM_007194.4(CHEK2):c.170C>T (p.Ser57Phe)

Gene:
CHEK2:checkpoint kinase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q12.1
Genomic location:
Preferred name:
NM_007194.4(CHEK2):c.170C>T (p.Ser57Phe)
Other names:
p.S57F:TCT>TTT
HGVS:
  • NC_000022.11:g.28734552G>A
  • NG_008150.2:g.12315C>T
  • NM_001005735.2:c.170C>T
  • NM_001257387.2:c.-608C>T
  • NM_001349956.2:c.170C>T
  • NM_007194.4:c.170C>TMANE SELECT
  • NM_145862.2:c.170C>T
  • NP_001005735.1:p.Ser57Phe
  • NP_001336885.1:p.Ser57Phe
  • NP_009125.1:p.Ser57Phe
  • NP_665861.1:p.Ser57Phe
  • LRG_302t1:c.170C>T
  • LRG_302:g.12315C>T
  • LRG_302p1:p.Ser57Phe
  • NC_000022.10:g.29130540G>A
  • NG_008150.1:g.12283C>T
  • NM_007194.3:c.170C>T
Protein change:
S57F
Links:
dbSNP: rs730881695
NCBI 1000 Genomes Browser:
rs730881695
Molecular consequence:
  • NM_001257387.2:c.-608C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001005735.2:c.170C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349956.2:c.170C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007194.4:c.170C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_145862.2:c.170C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000211006GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Uncertain significance
(Mar 2, 2023)
germlineclinical testing

Citation Link,

SCV004042144CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Uncertain significance
(Sep 1, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000211006.15

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in individuals with breast or pancreatic cancer (Schoolmeester et al., 2017; Cremin et al., 2020); Published functional studies demonstrate no damaging effect: growth similar to wild type after DNA damage (Delimitsou et al., 2019); This variant is associated with the following publications: (PMID: 22114986, 11733767, 32255556, 28709830, 30851065)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV004042144.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

CHEK2: PM2, BS3:Supporting

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024